| pubmed-article:2155987 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2155987 | lifeskim:mentions | umls-concept:C0039005 | lld:lifeskim |
| pubmed-article:2155987 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:2155987 | lifeskim:mentions | umls-concept:C0037663 | lld:lifeskim |
| pubmed-article:2155987 | lifeskim:mentions | umls-concept:C0021665 | lld:lifeskim |
| pubmed-article:2155987 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:2155987 | lifeskim:mentions | umls-concept:C0021666 | lld:lifeskim |
| pubmed-article:2155987 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:2155987 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2155987 | pubmed:dateCreated | 1990-4-20 | lld:pubmed |
| pubmed-article:2155987 | pubmed:abstractText | Insulin-like growth factor-I (IGF-I) and IGF-II have been measured in plasma obtained from male and female pigs of two strains during daily administration of pituitary-derived porcine GH (pGH; 100 micrograms/kg) from 60 to 90 kg body weight. Each plasma sample was first chromatographed to separate the IGF from binding proteins in order to obtain reliable measurements. IGF-I concentrations showed no differences between strains, but were higher in untreated males (497 +/- 43 (S.E.M.) micrograms/l) than females (299 +/- 15 micrograms/l). GH-treated animals had two-fold higher concentrations of IGF-I. IGF-II concentrations were not significantly different between sexes or strains, but were decreased in pigs treated with pGH (299 +/- 28 micrograms/1) compared with controls (431 +/- 32 micrograms/l). Binding protein concentrations, measured as interference in the IGF-I and IGF-II assays, were not different between sexes or strains, but were increased in pGH-treated animals. Taken together, these results indicate that in addition to the expected increase in IGF-I concentrations, exogenous administration of pGH to pigs leads to an increase in IGF-binding protein and a depression in IGF-II concentrations. | lld:pubmed |
| pubmed-article:2155987 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2155987 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2155987 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2155987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2155987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2155987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2155987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2155987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2155987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2155987 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2155987 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:2155987 | pubmed:issn | 0022-0795 | lld:pubmed |
| pubmed-article:2155987 | pubmed:author | pubmed-author:JohnsonR JRJ | lld:pubmed |
| pubmed-article:2155987 | pubmed:author | pubmed-author:BallardF JFJ | lld:pubmed |
| pubmed-article:2155987 | pubmed:author | pubmed-author:CampbellR GRG | lld:pubmed |
| pubmed-article:2155987 | pubmed:author | pubmed-author:OwensP CPC | lld:pubmed |
| pubmed-article:2155987 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2155987 | pubmed:volume | 124 | lld:pubmed |
| pubmed-article:2155987 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2155987 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2155987 | pubmed:pagination | 269-75 | lld:pubmed |
| pubmed-article:2155987 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:meshHeading | pubmed-meshheading:2155987-... | lld:pubmed |
| pubmed-article:2155987 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2155987 | pubmed:articleTitle | Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. | lld:pubmed |
| pubmed-article:2155987 | pubmed:affiliation | CSIRO Division of Human Nutrition, Adelaide, South Australia. | lld:pubmed |
| pubmed-article:2155987 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2155987 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2155987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2155987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2155987 | lld:pubmed |
